Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06233604

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for hip arthroplasty

Detailed description

This study is proposed to explore the effect of perineurial Dexamethasone and Dexmedetomidine on erector spinal plane block duration for spine surgery. After spine surgery, patients need good analgesia. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe. The safety of local anaesthesia is essential due to the much lower toxicity threshold of local anaesthetics. An effective adjuvant, such as Dexamethasone or Dexmedetomidine, could allow for a higher dilution of local anaesthetics while maintaining and enhancing their analgesic effect. There is considerable research where intravenous and perineural dexamethasone and Dexmedetomidine use have been compared in adults. However, there is a massive lack of research regarding spine surgery and the Erector Spinae Plane Block. In this study, investigators compare perineural Dexamethasone and Dexmedetomidine. The investigator aims to find a dexamethasone or dexmedetomidine that covers the need for good pain relief and fast recovery postoperatively.

Conditions

Interventions

TypeNameDescription
DRUG0.9%sodium chlorideunilateral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block
DRUGDexamethasoneunilateral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block
DRUGDexmedetomidineunilateral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block

Timeline

Start date
2024-04-10
Primary completion
2025-03-30
Completion
2025-05-30
First posted
2024-01-31
Last updated
2024-04-29

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06233604. Inclusion in this directory is not an endorsement.